SAN DIEGO, CA - Cibus Inc., a prominent agricultural biotechnology company, has achieved a significant regulatory milestone with the California Rice Commission's Rice Certification Committee approving its field research proposal on February 26, 2025. This marks the first authorization for planting gene-edited Rice in California. Additionally, in April 2025, the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA-APHIS) designated two of Cibus' Canola traits as not regulated under USDA biotechnology regulations. These developments underscore Cibus' progress in advancing its proprietary gene editing technologies in the agricultural sector.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。